Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
Total CEO says company rejected Venture Global as LNG supplier over lack of trust
TotalEnergies rejected opportunities to become a long-term customer of Venture Global LNG's U.S. terminals because it did not trust the company, CEO Patrick Pouyanné told Reuters on Wednesday.
Home Health Care News20h
Baptist Health Forms Home Health Joint Venture With Alternate Solutions Health Network
Baptist Health has entered into a joint venture with Alternate Solutions Health Network (ASHN). The JV will be owned by Baptist Health and ASHN, and ...